Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Clinical trial NCT04393506 · COMPLETED
Trial details
- NCT number
- NCT04393506
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-23
- Primary completion
- 2020-11-02
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.